A new capsule for diabetic nerve pain when pregabalin doesn't work
Treatments studied
Part of Brain & nervous system, Hormones & metabolism, Pain clinical trials.
This trial tests an experimental drug (HSK16149) for people with long-term diabetic nerve pain that hasn't been helped enough by pregabalin. It aims to see if the new capsule can reduce pain more effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old
- You have had nerve pain from diabetes for at least 6 months
- You have taken pregabalin for over 4 weeks and it didn't work well enough
- Your average daily pain in the last day is at least 6 out of 10 on a pain scale
- Your blood sugar control is stable and you are on a steady diabetes medicine plan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called HRS-2129 for people with long-term nerve pain caused by diabetes. It aims to see if the drug can safely reduce pain.
This study tests a new drug (HL-1186) for diabetic nerve pain. It aims to see if it reduces pain safely in people with type 1 or type 2 diabetes who have had nerve pain for at least 6 months.
This trial tests an investigational drug for people with pain caused by nerve damage from diabetes (diabetic peripheral neuropathy). It may help reduce pain in your lower legs if other treatments haven't worked well.
This trial tests a new medicine called VX-993 for people with diabetes who have had nerve pain in both feet or legs for at least a year. The goal is to see if it reduces pain and is safe.
This trial tests an experimental medicine called suzetrigine to see if it can safely reduce pain caused by nerve damage from diabetes (diabetic peripheral neuropathy). It might be an option if you have had daily pain in both legs and current treatments haven't worked well enough.
This trial tests a new capsule (HSK16149) for people with moderate to severe central neuropathic pain (pain from a spinal cord injury, stroke, Parkinson's, or multiple sclerosis). It aims to see if the drug can safely reduce pain and improve quality of life.
Hear when a new Diabetic Peripheral Neuropathic Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.